GGrantIndex
Sort

16,300 grants matching fatty liver disease

The Mitochondrial Calcium Uniporter: Implications for NAFLD and Hepatic Insulin Resistance

$47,694
Traci Ellen Lamoia · Yale University · F31 · FY2023 · DK

Leveraging arginine catabolism to treat metabolic diseases

$47,694
Yiming Zhang · Washington University · F31 · FY2023 · DK

Localization and regulation of metabolic gene expression in response to dietary triglycerides

$47,694
Michelle Biederman · Johns Hopkins University · F31 · FY2023 · DK

Molecular and cancer-related roles of ACLY exon 14

$47,694
Julianna Supplee · University Of Pennsylvania · F31 · FY2023 · CA

ATG2 mediated lipid transport is essential for lipid droplet homeostasis

$47,694
Justin Korfhage · Yale University · F31 · FY2023 · DK

Alcohol-associated liver disease facilitates lobule scale metabolic reprogramming to modulate regeneration

$47,694
Alexandra Rose Manchel · Thomas Jefferson University · F31 · FY2023 · AA

Novel Transcriptional & Post-Transcriptional Regulators of Endothelial Metabolism in Atherosclerosis

$47,694
Kathryn Citrin · Yale University · F31 · FY2023 · HL

Jagged-Notch signaling in NASH/fibrosis

$47,692
Utpal Pajvani · Columbia University Health Sciences · R01 · FY2022 · DK

A2b Adenosine Receptor Regulation of Metabolic Disease and Inflammation

$47,676
Anna Eisenstein · Boston University Medical Campus · F30 · FY2014 · DK

RBP4, Inflammation, and Insulin Resistance

$47,606
Julie Elizabeth Norseen · Beth Israel Deaconess Medical Center · F32 · FY2010 · DK

HIGH FAT DIET INDUCED ALTERATIONS IN GENE EXPRESSION IN THE NONHUMAN PRIMATE

$47,603
Kevin L Grove · Oregon Health & Science University · P51 · FY2010 · RR

Ceramides as novel drivers of metabolic dysfunction and colorectal cancer

$47,420
Mary Christine Playdon · University Of Utah · U01 · FY2024 · CA

Ceramides as novel drivers of metabolic dysfunction and colorectal cancer

$47,420
Mary Christine Playdon · Utah State Higher Education System--University Of Utah · U01 · FY2025 · CA

NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) DATABASE

$47,355
Arun J Sanyal · Virginia Commonwealth University · M01 · FY2010 · RR

Aging and CR effects on the Plasma Membrane Redox System

$47,279
Rafael De Cabo · National Institute On Aging · ZIA · FY2021 · AG

Role for tissue-type plasminogen activator in suppression of hepatic fibrosis

$47,232
Liang-I Kang · University Of Pittsburgh At Pittsburgh · F30 · FY2013 · DK

Mechanisms by which the protein kinase IKKi regulates energy expenditure

$47,232
Jonathan Carl Mowers · University Of Michigan At Ann Arbor · F30 · FY2012 · DK

Role for tissue-type plasminogen activator in suppression of hepatic fibrosis

$47,232
Liang-I Kang · University Of Pittsburgh At Pittsburgh · F30 · FY2012 · DK

Metabolic Characterization of the Novel Adipokine CTRP3

$47,210
Jonathan M Peterson · Johns Hopkins University · F32 · FY2009 · DK

Roles for Rho Proteins During Specific Stages of Breast Cancer Metastasis.

$47,210
John Lamar · Massachusetts Institute Of Technology · F32 · FY2009 · CA

Pancreatic fat and volume and childhood metabolic health

$47,163
Catherine Cioffi Cohen · University Of Colorado Denver · K99 · FY2025 · DK

Role of SIRT3 in Modulation of Lipotoxicity in Liver

$47,114
Sean A. Newsom · University Of Colorado Denver · F32 · FY2012 · DK

Role of SCD1 and Dietary Methionine Restriction on Energy Homeostasis

$47,063
Eric Paul Plaisance · Lsu Pennington Biomedical Research Ctr · F32 · FY2011 · DK

Fatty Acid Binding Protein and Pathological Retinal Vascularization

$47,000
Sule Cataltepe · Brigham And Women'S Hospital · R21 · FY2012 · EY

NORC - admin supplement

$46,980
Eric Ravussin · Lsu Pennington Biomedical Research Ctr · P30 · FY2023 · DK